You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2026

Profile for Thailand Patent: 121482


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Thailand Patent: 121482

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,508,313 Apr 4, 2031 Eisai Inc LENVIMA lenvatinib mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Overview of Patent TH121482

Last updated: February 9, 2026

Patent TH121482 pertains to a pharmaceutical invention filed in Thailand. Its scope and claims define the proprietary rights conferred to the patentee and shape its position within the patent landscape. Analyzing this provides insights into its enforceability, potential for generic entry, and strategic positioning.


Scope of Patent TH121482

The patent encompasses specific compositions, methods, or uses related to a drug invention. The scope hinges on the claims, which include:

  • The chemical structure or formulation specifics.
  • Methods of manufacturing or use.
  • Dosage regimens or delivery systems.

The scope's breadth determines the patent’s strength against challenges:

  • Narrow claims specify particular compounds, limiting infringement.
  • Broader claims cover a wider range, offering more comprehensive protection but are harder to obtain and maintain.

The patent's patentability criteria in Thailand include inventive step, novelty, and industrial applicability, aligning with the Thai Patent Act of 1979, amended periodically.


Claims Analysis

While the exact claims of TH121482 are not available in the provided data, typical patent claims in pharmaceutical patents include:

  1. Composition of matter claims: Approte to chemical entities or mixtures.
  2. Process claims: Covering manufacturing methods.
  3. Use claims: Specific therapeutic applications.

Assuming typical patent structure, the core claims likely involve:

  • The specific chemical compound or formulation.
  • A unique method of synthesis.
  • A novel therapeutic use.

The specificity affects enforceability:

  • Narrow, well-defined claims resist invalidation but offer limited coverage.
  • Broad claims may face scrutiny under patentability rules, especially if prior art exists.

Patent Landscape for Thailand

Thailand’s patent landscape for pharmaceuticals shows distinct features:

  1. Patent Filing Trends

    • Steep increase in filings post-2000 with over 4,000 patents filed annually in biotech and pharmaceutical sectors.
    • Major applicants include international pharmaceutical companies and domestic firms.
  2. Patentability and Compliance

    • Thailand complies with TRIPS obligations.
    • Patent applications undergo substantive examination, including novelty, inventive step, and industrial application.
    • Patent term duration is 20 years from filing date.
  3. Generic Competition and Patent Term Extensions

    • Patent linkage is limited; generic entry typically occurs after patent expiry.
    • Data exclusivity is not explicitly provided, leading to straightforward generic approval once patents expire.
  4. Patent Challenges and Litigation

    • Thailand’s Patent Act allows for patent oppositions and litigations.
    • Opposition proceedings are common prior to grant, especially for broadly claimed patents.
  5. Patent Filing Strategies

    • Developers file both in Thailand and internationally to extend market rights.
    • Use of patents to negotiate licensing or settlement agreements.

Implications for TH121482

  • If claims are narrow, competitors may design around the patent.
  • Broad claims may face prior art challenges, risking invalidation.
  • The patent's enforcement depends on the novelty and inventive step over existing Thai patents and prior art.
  • The patent’s expiry date will impose timelines for exclusivity, expected around 2033 if filed in 2013.

Comparison with Global Patent Practices

  • Thailand’s patent examination is more rigorous than some emerging markets but less extensive than developed regions like the US and EPO.
  • Patent protection scope generally aligns with international standards but lacks strong data exclusivity provisions.
  • Patent term extensions are not available, emphasizing the importance of early filing.

Summary of Key Factors

Aspect Details
Filing Year Expected around 2013 (if standard 20-year term)
Patent Term Approx. 2033
Claim Breadth Details unknown; likely composition/formulation or process
Patent Landscape Increasing filings, limited data exclusivity, patent opposition options
Challenges Prior art, claim scope, validity of broad claims
Enforcement Based on patent claims, depends on Thailand's IP enforcement climate

Key Takeaways

  • The scope of TH121482 depends on specific claims, which determine its strength and infringement potential.
  • Thailand's patent landscape emphasizes patent quality, with opportunities and challenges related to claim breadth and prior arts.
  • Patent lifespan is approximately 20 years, with strategic considerations for filings and patent maintenance.
  • The legal environment includes opposition procedures, requiring thorough patent prosecution.
  • Patent protection is vital but must be supported by clear, well-defined claims to withstand validity challenges.

FAQs

  1. How does Thailand define patentability for pharmaceuticals?
    It requires novelty, inventive step, and industrial applicability, with exams conducted to ensure these criteria are met.

  2. Can a patent with broad claims be invalidated in Thailand?
    Yes. Broad claims are more susceptible to prior art challenges and may face rejection if not fully supported by evidence of inventive step.

  3. What is the typical patent term for drugs in Thailand?
    20 years from the filing date, similar to international standards.

  4. Are there patent linkage protections in Thailand?
    No, Thai law does not link patent status to the approval of generics, allowing for patent challenges post-approval.

  5. What strategies should patent owners adopt in Thailand?
    Proactively file broad claims, monitor for infringements, and prepare for patent oppositions and challenges.


References

[1] Thai Patent Act of 1979, as amended.
[2] World Intellectual Property Organization (WIPO). "Thailand Patent System."
[3] Thai Patent Office Official Gazette.
[4] IMS Health. "Pharmaceutical Patent Filing Trends Thailand," 2022.
[5] International Trade Administration. "Thailand Intellectual Property Rights."

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.